查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1602654

脫髮症治療藥物市場：按脫髮症類型、性別、給藥途徑分類 - 全球預測 2025-2030

Alopecia Drugs Market by Alopecia Types (Alopecia Areata, Alopecia Totalis, Alopecia Universalis), Gender (Men, Women), Route of Administration - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

脫髮症治療藥物市場2023年估值為12.3億美元，預計到2024年將達到13.7億美元，複合年成長率為11.90%，到2030年將達到27億美元。

脫髮症治療市場包括用於治療脫發病症（例如脫髮症、雄性禿和脫髮症擴張）的藥物。這些藥物包括米諾地爾等局部藥物、Finasteride等口服藥物以及 JAK 抑制劑等新產品。脫髮對心理和心理的影響以及不同人群脫髮症盛行率的增加強調了對這些藥物的需求。治療目標範圍從皮膚病學目的到美容增強，主要最終用戶包括個人消費者、皮膚科診所和專門的頭髮治療中心。

主要市場統計
基準年[2023] 12.3億美元
預測年份 [2024] 13.7億美元
預測年份 [2030] 27億美元
複合年成長率（%） 11.90%

該市場的成長主要是由於人們對脫髮治療的認知和接受程度的提高、藥物研究的技術進步以及容易脫髮的老年人口的增加而推動的。電子商務平台的擴張也透過提高產品的可用性來推動市場滲透。此外，最近的發展凸顯了再生醫學和生技藥品用於長期治療脫髮症的機會。公司可以利用基因治療和個人化醫療領域不斷擴大的研究，在分子層面解決特定的脫髮症類型。

然而，市場面臨先進治療方法的高成本、潛在的副作用以及延遲藥物核准的嚴格監管要求等挑戰。此外，市場成長受到與脫髮相關的社會文化恥辱的限制，這阻礙了一些消費者尋求治療。此外，線上仿冒品對消費者和值得信賴的製造商都構成風險。

隨著經皮吸收貼片和微針等侵入性較小的藥物傳遞方法的發展，創新可能會蓬勃發展。對脫髮症的遺傳學研究可能會帶來標靶治療的突破。這個以藥品和消費品為導向的市場的性質表明，製藥公司需要與化妝品品牌進行協同效應，以確保治療既有效又對使用者有吸引力。

市場動態：快速發展的脫髮症治療市場的主要市場洞察

供需的動態交互作用正在改變脫髮症藥物市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助消費行為及其對製造業的影響。

  • 市場促進因素
    • 全球自體免疫疾病流行
    • 不健康的生活方式和缺乏運動的現象正在增加
    • 更多非政府組織提高人們對脫髮症的認知
  • 市場限制因素
    • 對脫髮症治療藥物及其有效性的不良健康影響的擔憂
  • 市場機會
    • 新監管機構核准脫髮症的新型系統治療方法
    • 加速脫髮症管理的研發活動
  • 市場挑戰
    • 人們越來越偏好植髮和美容治療

波特的五力：駕馭脫髮症藥物市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解脫髮症治療藥物市場的外部影響

外部宏觀環境因素在塑造脫髮症治療藥物市場的表現動態中起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解脫髮症治療藥物市場的競爭狀況

對脫髮症治療藥物市場的詳細市場佔有率分析可以對供應商的業績進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣脫髮症治療市場供應商的績效評估

FPNV 定位矩陣是評估脫髮症治療藥物市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議，描繪脫髮症治療市場的成功之路

對於旨在加強在全球市場的影響力的公司來說，脫髮症治療藥物市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 全球自體免疫疾病盛行率增加
      • 不健康的生活方式和缺乏運動的現象正在增加
      • 更多非政府組織提高人們對脫髮症的認知
    • 抑制因素
      • 對脫髮症治療藥物對健康的不良影響和功效的擔憂
    • 機會
      • 新監管機構核准脫髮症新系統治療方法
      • 加速脫髮症治療的研究和開發
    • 任務
      • 對頭髮生長和美容療程的興趣正在迅速增加
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章按脫髮症類型分類的脫髮症治療藥物市場

  • 脫髮症
  • 全脫髮症
  • 全身性脫髮症

第7章脫髮症治療藥物市場性別

  • 男性
  • 女士

第8章脫髮症治療藥物市場：依給藥途徑

  • 可注射的
  • 口服
  • 話題

第9章 北美和南美脫髮症治療藥物市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太脫髮症治療市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲的脫髮症治療藥物市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • FDA核准輝瑞公司脫髮症治療藥物
    • Sun Pharma 將以 5.76 億美元收購美國Concert Pharmaceuticals
    • FDA核准公司和 Insight 的Olumiant（Baricitinib）作為第一個也是唯一一個治療成人嚴重脫髮症的全身治療藥物
  • 戰略分析和建議

公司名單

  • AndroScience Corporation
  • Capillus, LLC by Curallux, LLC
  • Cipla Inc.
  • Concert Pharmaceuticals, Inc.
  • Daiichi Sankyo Company, Ltd.
  • Dr. Reddy's Laboratories Ltd.
  • Eli Lilly and Company
  • Hairline Co.
  • Merck & Co., Inc.
  • The Himalaya Drug Company
  • Vitabiotics Ltd.
Product Code: MRR-436901065B9F

The Alopecia Drugs Market was valued at USD 1.23 billion in 2023, expected to reach USD 1.37 billion in 2024, and is projected to grow at a CAGR of 11.90%, to USD 2.70 billion by 2030.

The alopecia drugs market encompasses pharmaceuticals designed to treat hair loss conditions such as alopecia areata, androgenetic alopecia, and telogen effluvium. These medications include topical treatments like minoxidil, oral medications like finasteride, and newer entrants like JAK inhibitors. The necessity for these drugs is underscored by the emotional and psychological impacts of hair loss, coupled with the rising incidence of alopecia across diverse demographics. Applications extend from dermatological purposes to cosmetic enhancements, with key end-users including individual consumers, dermatology clinics, and specialty hair treatment centers.

KEY MARKET STATISTICS
Base Year [2023] USD 1.23 billion
Estimated Year [2024] USD 1.37 billion
Forecast Year [2030] USD 2.70 billion
CAGR (%) 11.90%

Growth in this market is primarily driven by increasing awareness and acceptance of hair loss treatments, technological advancements in pharmaceutical research, and a growing geriatric population who are more susceptible to hair thinning. The expansion of e-commerce platforms also aids market penetration by making products more accessible. Moreover, recent developments highlight opportunities in regenerative medicine and biologics, catering to the long-term management of alopecia conditions. Companies could capitalize on expanding research into gene therapy and personalized medicine, addressing specific alopecia types at a molecular level.

However, the market faces challenges such as high costs of advanced treatments, potential side effects, and stringent regulatory requirements that delay drug approvals. Additionally, market growth is limited by the socio-cultural stigma associated with hair loss that deters some consumers from seeking treatment. Furthermore, counterfeit products online pose a risk to both consumers and credible manufacturers.

Innovation can thrive in the development of less invasive delivery methods for drugs, such as transdermal patches and microneedles, which could enhance therapeutic outcomes and consumer acceptance. Research into understanding the genetics of alopecia offers potential breakthroughs in targeted therapies. The nature of this market, being both drug and consumer goods-oriented, suggests a need for pharmaceutical companies to synergize with cosmetic brands, ensuring treatments are both effective and appeal aesthetically to users.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Alopecia Drugs Market

The Alopecia Drugs Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing prevalence of autoimmune diseases across the globe
    • Surging adoption of unhealthy lifestyles and physical inactivity
    • Increasing number of NGOs to create awareness about alopecia condition
  • Market Restraints
    • Adverse health impact of alopecia drugs and concern with drugs efficacy
  • Market Opportunities
    • Emerging regulatory approvals for the novel systemic treatment for alopecia areata
    • Accelerating research and developments activities for alopecia management
  • Market Challenges
    • Surge in preference for the hair growth transplant and cosmetic treatment

Porter's Five Forces: A Strategic Tool for Navigating the Alopecia Drugs Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Alopecia Drugs Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Alopecia Drugs Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Alopecia Drugs Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Alopecia Drugs Market

A detailed market share analysis in the Alopecia Drugs Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Alopecia Drugs Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Alopecia Drugs Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Alopecia Drugs Market

A strategic analysis of the Alopecia Drugs Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Alopecia Drugs Market, highlighting leading vendors and their innovative profiles. These include AndroScience Corporation, Capillus, LLC by Curallux, LLC, Cipla Inc., Concert Pharmaceuticals, Inc., Daiichi Sankyo Company, Ltd., Dr. Reddy's Laboratories Ltd., Eli Lilly and Company, Hairline Co., Merck & Co., Inc., The Himalaya Drug Company, and Vitabiotics Ltd..

Market Segmentation & Coverage

This research report categorizes the Alopecia Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Alopecia Types, market is studied across Alopecia Areata, Alopecia Totalis, and Alopecia Universalis.
  • Based on Gender, market is studied across Men and Women.
  • Based on Route of Administration, market is studied across Injectable, Oral, and Topical.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of autoimmune diseases across the globe
      • 5.1.1.2. Surging adoption of unhealthy lifestyles and physical inactivity
      • 5.1.1.3. Increasing number of NGOs to create awareness about alopecia condition
    • 5.1.2. Restraints
      • 5.1.2.1. Adverse health impact of alopecia drugs and concern with drugs efficacy
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging regulatory approvals for the novel systemic treatment for alopecia areata
      • 5.1.3.2. Accelerating research and developments activities for alopecia management
    • 5.1.4. Challenges
      • 5.1.4.1. Surge in preference for the hair growth transplant and cosmetic treatment
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Alopecia Drugs Market, by Alopecia Types

  • 6.1. Introduction
  • 6.2. Alopecia Areata
  • 6.3. Alopecia Totalis
  • 6.4. Alopecia Universalis

7. Alopecia Drugs Market, by Gender

  • 7.1. Introduction
  • 7.2. Men
  • 7.3. Women

8. Alopecia Drugs Market, by Route of Administration

  • 8.1. Introduction
  • 8.2. Injectable
  • 8.3. Oral
  • 8.4. Topical

9. Americas Alopecia Drugs Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Alopecia Drugs Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Alopecia Drugs Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. FDA Approves Pfizer's Alopecia Drug
    • 12.3.2. Sun Pharma to acquire US-based Concert Pharmaceuticals for USD 576 million
    • 12.3.3. FDA Approves Lilly and Incyte's OLUMIANT (baricitinib) As First and Only Systemic Medicine for Adults with Severe Alopecia Areata
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AndroScience Corporation
  • 2. Capillus, LLC by Curallux, LLC
  • 3. Cipla Inc.
  • 4. Concert Pharmaceuticals, Inc.
  • 5. Daiichi Sankyo Company, Ltd.
  • 6. Dr. Reddy's Laboratories Ltd.
  • 7. Eli Lilly and Company
  • 8. Hairline Co.
  • 9. Merck & Co., Inc.
  • 10. The Himalaya Drug Company
  • 11. Vitabiotics Ltd.

LIST OF FIGURES

  • FIGURE 1. ALOPECIA DRUGS MARKET RESEARCH PROCESS
  • FIGURE 2. ALOPECIA DRUGS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ALOPECIA DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ALOPECIA DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ALOPECIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS ALOPECIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS ALOPECIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES ALOPECIA DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES ALOPECIA DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC ALOPECIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC ALOPECIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ALOPECIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ALOPECIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ALOPECIA DRUGS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. ALOPECIA DRUGS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ALOPECIA DRUGS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ALOPECIA DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ALOPECIA DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ALOPECIA DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ALOPECIA DRUGS MARKET DYNAMICS
  • TABLE 7. GLOBAL ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA AREATA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TOTALIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA UNIVERSALIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ALOPECIA DRUGS MARKET SIZE, BY MEN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ALOPECIA DRUGS MARKET SIZE, BY WOMEN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ALOPECIA DRUGS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ALOPECIA DRUGS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ALOPECIA DRUGS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS ALOPECIA DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES ALOPECIA DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC ALOPECIA DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA ALOPECIA DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 145. ALOPECIA DRUGS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 146. ALOPECIA DRUGS MARKET, FPNV POSITIONING MATRIX, 2023